Live Price
Live Volume
Chart Volume 0
Volume 0
5 secQuince Therapeutics Market Segments
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $31.00 |
|---|---|
| Close | $31.00 |
| Low | $31.00 |
| Low Change | 0.00 (0.00%) |
| High | $31.00 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 284 |
| Dollar Volume | $8.80K |
Regular Trading Hours Yesterday
+1.13(+3.82%)
| Open | $29.46 |
|---|---|
| Close | $30.59 |
| Low | $28.54 |
| Low Change | -0.92 (-3.13%) |
| High | $30.90 |
| High Change | +1.44 (+4.89%) |
| Range | $2.36 |
| Volume | 6.487K |
| Dollar Volume | $198.40K |
Premarket Yesterday
*No Trades in Segment
Quince Therapeutics News
7 months agobenzinga.comWhat Sparked Quince Therapeutics (QNCX) Stock To Rise 53% After Hours
7 months agoinvesting.comQuince Therapeutics stock plummets after revealing strategic alternatives
- 8 months agoinvesting.com
Quince Therapeutics stock soars after engaging LifeSci Capital as advisor
- 8 months agoinvesting.com
Quince Therapeutics stock tumbles after failed Phase 3 trial results
Quince Therapeutics Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Quince Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $28.59 |
|---|---|
| 10 Day Moving Average (SMA10) | $28.91 |
| 20 Day Moving Average (SMA20) | $30.49 |
| 50 Day Moving Average (SMA50) | $27.44 |
| 100 Day Moving Average (SMA100) | $15.55 |
| 200 Day Moving Average (SMA200) | $8.54 |
Quince Therapeutics Statistics
| Average Volume (30 Days) | 24.04K |
|---|---|
| P/E Ratio (Current) | -.31 |
| EPS (Current) | -$93.99 |
| Dividend Yield | 0.00% |
| Free Cash Flow | — |
| Cash Ratio | 13.64 |
| Current Ratio | 14.52 |
| Quick Ratio | 14.52 |
| Debt to Equity | 0.00 |
| Enterprise Value | -$86.00M |
| EV to EBITDA | 0.68 |
| EV to Sales | — |
| Price to Book | 0.28 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.77% |
| Return on Equity | -0.88% |
Quince Therapeutics Stock Splits
There have been 2 stock splits for Quince Therapeutics (QNCX). The last reverse stock split occured on June 30, 2026 and reduced the outstanding shares at a ratio of 20:1.
| Date | Type | Ratio |
|---|---|---|
| Jun 30, 2026 | Reverse | 20:1 |
| Apr 13, 2026 | Reverse | 10:1 |
Quince Therapeutics Dividends
There have been no dividends for Quince Therapeutics (QNCX).